← Back
$VRNA All transactions

Verona Pharma plc

▼ SELL 10b5-1 Plan

$ Value

$1.1M

Shares

120,384

Price

$9

Filed

May 22

Insider

Name

Sinha Vikas

Title

CIK

0001337845

Roles

Director

Transaction Details

Transaction Date

2025-04-29

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

74,440

Footnotes

This Form 4 amendment is being filed to correct the Reporting Person's Form 4 filed on May 1, 2025 which erroneously presented all transacted securities in American Depositary Shares ("ADSs") instead of Ordinary Shares. | Reported securities are represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer. | The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on November 6, 2024, solely with the intent to cover payment of the exercise price. | Consists of 74,440 Ordinary Shares represented by 9,305 ADSs. | The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer. | The option is fully vested.

Filing Info

Accession No.

0001104659-25-051979

Form Type

4/A

Issuer CIK

0001657312

Sinha Vikas's History

Date Ticker Type Value
2026-04-16 SRRK $516K
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-08-01 VRNA M $0

Other Insiders at VRNA (90d)

No other insider activity at this issuer in the last 90 days.